These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats. Li S; Liao X; Meng F; Wang Y; Sun Z; Guo F; Li X; Meng M; Li Y; Sun C PLoS One; 2014; 9(1):e86724. PubMed ID: 24489777 [TBL] [Abstract][Full Text] [Related]
45. Cholic acid supplementation accelerates the progression of nonalcoholic fatty liver disease to the procarcinogenic state in mice fed a high-fat and high-cholesterol diet. Chun HJ; Shim YJ; Kwon YH J Nutr Biochem; 2022 Feb; 100():108869. PubMed ID: 34563665 [TBL] [Abstract][Full Text] [Related]
46. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice. Lee MR; Yang HJ; Park KI; Ma JY Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424 [TBL] [Abstract][Full Text] [Related]
47. Maslinic acid protects against obesity-induced nonalcoholic fatty liver disease in mice through regulation of the Sirt1/AMPK signaling pathway. Liou CJ; Dai YW; Wang CL; Fang LW; Huang WC FASEB J; 2019 Nov; 33(11):11791-11803. PubMed ID: 31361524 [TBL] [Abstract][Full Text] [Related]
48. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1. Wu L; Liu Y; Zhao Y; Li M; Guo L Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490 [TBL] [Abstract][Full Text] [Related]
49. Attenuation by Tetrahydrocurcumin of Adiposity and Hepatic Steatosis in Mice with High-Fat-Diet-Induced Obesity. Pan MH; Chen JW; Kong ZL; Wu JC; Ho CT; Lai CS J Agric Food Chem; 2018 Dec; 66(48):12685-12695. PubMed ID: 30415544 [TBL] [Abstract][Full Text] [Related]
50. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice. Lee H; Ahn J; Shin SS; Yoon M Int J Obes (Lond); 2019 Aug; 43(8):1620-1630. PubMed ID: 30283077 [TBL] [Abstract][Full Text] [Related]
51. JianPi-QingHua formula attenuates nonalcoholic fatty liver disease by regulating the AMPK/SIRT1/NF-κB pathway in high-fat-diet-fed C57BL/6 mice. Tian J; Cai M; Jin S; Chen Q; Xu J; Guo Q; Yan Z; Han X; Lu H Pharm Biol; 2023 Dec; 61(1):647-656. PubMed ID: 37038833 [TBL] [Abstract][Full Text] [Related]
52. Apigenin, a modulator of PPARγ, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation. Feng X; Yu W; Li X; Zhou F; Zhang W; Shen Q; Li J; Zhang C; Shen P Biochem Pharmacol; 2017 Jul; 136():136-149. PubMed ID: 28414138 [TBL] [Abstract][Full Text] [Related]
53. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice. Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834 [TBL] [Abstract][Full Text] [Related]
54. Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway. Li M; Xu C; Shi J; Ding J; Wan X; Chen D; Gao J; Li C; Zhang J; Lin Y; Tu Z; Kong X; Li Y; Yu C Gut; 2018 Dec; 67(12):2169-2180. PubMed ID: 28877979 [TBL] [Abstract][Full Text] [Related]
55. Modulation of xenobiotic nuclear receptors in high-fat diet induced non-alcoholic fatty liver disease. Li X; Wang Z; Klaunig JE Toxicology; 2018 Dec; 410():199-213. PubMed ID: 30120929 [TBL] [Abstract][Full Text] [Related]
56. A potential probiotic bacterium for antipsychotic-induced metabolic syndrome: mechanisms underpinning how Akkermansia muciniphila subtype improves olanzapine-induced glucose homeostasis in mice. Huang D; Gao J; Li C; Nong C; Huang W; Zheng X; Li S; Peng Y Psychopharmacology (Berl); 2021 Sep; 238(9):2543-2553. PubMed ID: 34046717 [TBL] [Abstract][Full Text] [Related]
57. Hepatic metabolic adaptation and adipose tissue expansion are altered in mice with steatohepatitis induced by high-fat high sucrose diet. Baiges-Gaya G; Fernández-Arroyo S; Luciano-Mateo F; Cabré N; Rodríguez-Tomàs E; Hernández-Aguilera A; Castañé H; Romeu M; Nogués MR; Camps J; Joven J J Nutr Biochem; 2021 Mar; 89():108559. PubMed ID: 33264665 [TBL] [Abstract][Full Text] [Related]
58. Effects of XIAP on high fat diet-induced hepatic steatosis: a mechanism involving NLRP3 inflammasome and oxidative stress. Zilu S; Qian H; Haibin W; Chenxu G; Deshuai L; Qiang L; Linfeng H; Jun T; Minxuan X Aging (Albany NY); 2019 Dec; 11(24):12177-12201. PubMed ID: 31841118 [TBL] [Abstract][Full Text] [Related]
59. Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity. Angelini G; Castagneto-Gissey L; Casella-Mariolo J; Caristo ME; Russo MF; Lembo E; Verrastro O; Stefanizzi G; Marini PL; Casella G; Bornstein SR; Rubino F; Mingrone G Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G502-G511. PubMed ID: 32812775 [TBL] [Abstract][Full Text] [Related]
60. PCSK9 dysregulates cholesterol homeostasis and triglyceride metabolism in olanzapine-induced hepatic steatosis via both receptor-dependent and receptor-independent pathways. Huang P; Ran J; Zhu W; Dai W; Tang Y; Lian P; Huang X; Li R FASEB J; 2024 Feb; 38(4):e23464. PubMed ID: 38358343 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]